LORIGERLIMAB

UNII:	JM802R57SA
Formula:
Preferred Substance Name:	LORIGERLIMAB
GSRS Full Record:	JM802R57SA i

2416595-46-3
AEX1344
AEX-1344
IMMUNOGLOBULIN, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS CLONE MG13.78 .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGGSGGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN CLONE 4B6 HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGCGGG) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC E-COIL) FUSION PROTEIN WITH IMMUNOGLOBULIN G4 (10-PROLINE,34-TYROSINE,36-THREONINE,38-GLUTAMIC ACID,DE-229-LYSINE) (HUMAN .GAMMA.4-CHAIN C REGION C-TERMINAL FRAGMENT), DISULFIDE WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN CLONE 4B6 .KAPPA.-CHAIN V-J REGION) FUSION PROTEIN WITH LINKER PEPTIDE (GGGSGGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS CLONE MG13.78 HEAVY CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GGCGGG) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC K-COIL), DIMER
LORIGERLIMAB [INN]
LORIGERLIMAB [USAN]
LORIGERLIMAB [WHO-DD]
MGD019
MGD-019

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LORIGERLIMAB

Synonyms and Mappings

Resources